|
|
???tair.name??? >
???browser.page.title.author???
|
"tassaneeyakul w"???jsp.browse.items-by-author.description???
Showing items 1-10 of 10 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-07-03T03:34:49Z |
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
|
Tassaneeyakul W.; Jantararoungtong T.; PEI-JER CHEN; Lin P.-Y.; Tiamkao S.; Khunarkornsiri U.; Chucherd P.; Konyoung P.; Vannaprasaht S.; Choonhakarn C.; Pisuttimarn P.; Sangviroon A.; Tassaneeyakul W. |
| 臺大學術典藏 |
2021-07-03T03:34:43Z |
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
|
Tassaneeyakul W.; Tiamkao S.; Jantararoungtong T.; PEI-JER CHEN; Lin S.-Y.; Chen W.-H.; Konyoung P.; Khunarkornsiri U.; Auvichayapat N.; Pavakul K.; Kulkantrakorn K.; Choonhakarn C.; Phonhiamhan S.; Piyatrakul N.; Aungaree T.; Pongpakdee S.; Yodnopaglaw P. |
| 臺大學術典藏 |
2021-07-03T03:34:33Z |
HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
|
Kulkantrakorn K.; Tassaneeyakul W.; Tiamkao S.; Jantararoungtong T.; Prabmechai N.; Vannaprasaht S.; Chumworathayi P.; PEI-JER CHEN; Sritipsukho P. |
| 中山醫學大學 |
2021 |
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians
|
Wang, CW; Tassaneeyakul, W; Chen, CB; Chen, WT; Teng, YC; Huang, CY; Sukasem, C; Lu, CW; Lee, YS; Choon, SE; Nakkam, N; Hui, RCY; Huang, YH; Chang, YC; Lin, YYW; Chang, CJ; Chiu, TM; Chantratita, W; Konyoung, P; Lee, CN; Klaewsongkram, J; Rerkpattanapipat, T; Amornpinyo, W; Saksit, N; Rerknimitr, P; Huang, YH; Lin, SH; Hsu, CK; Chan, CC; Lin, YJ; Hung, SI; Chung, WH |
| 國立成功大學 |
2021 |
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians
|
Wang, C.-W.;Tassaneeyakul, W.;Chen, Chen C.-B.;Chen, W.-T.;Teng, Y.-C.;Huang, C.-Y.;Sukasem, C.;Lu, C.-W.;Lee, Y.-S.;Choon, S.-E.;Nakkam, Nakkam N.;Hui, R.C.-Y.;Huang, Y.-H.;Chang, Y.-C.;Lin, Y.Y.-W.;Chang, Chang C.-J.;Chiu, T.-M.;Chantratita, W.;Konyoung, P.;Lee, C.-N.;Klaewsongkram, J.;Rerkpattanapipat, T.;Amornpinyo, W.;Saksit, N.;Rerknimitr, P.;Huang, Y.H.;Lin, S.-H.;Hsu, C.-K.;Chan, Chan C.-C.;Lin, Y.-J.;Hung, S.-I.;Chung, W.-H.;Consortium, Taiwan/Asian Severe Cutaneous Adverse Reaction |
| 臺大學術典藏 |
2019-12-04T08:43:33Z |
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
|
Chen C.-B.;Hsiao Y.-H.;Wu T.;Hsih M.-S.;Tassaneeyakul W.;Jorns T.P.;Sukasem C.;Hsu C.-N.;Su S.-C.;Chang W.-C.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Sun P.-L.;Lee H.-E.;Yang C.-Y.;Kao P.-H.;Yang C.-H.;Ho H.-C.;Lin J.-Y.;Chang Y.-C.;Chen M.-J.;Lu C.-W.;Ng C.Y.;Kuo K.-L.;Lin C.-Y.;Yang C.-S.;Chen D.-P.;Chang P.-Y.;Wu T.-L.;Lin Y.-J.;Weng Y.-C.;Kuo T.-T.;Hung S.-I.;Chung W.-H.;For The Taiwan Severe Cutaneous Adverse Reaction Consortium; Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium |
| 臺大學術典藏 |
2019-12-04T08:43:33Z |
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
|
Chen C.-B.;Hsiao Y.-H.;Wu T.;Hsih M.-S.;Tassaneeyakul W.;Jorns T.P.;Sukasem C.;Hsu C.-N.;Su S.-C.;Chang W.-C.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Sun P.-L.;Lee H.-E.;Yang C.-Y.;Kao P.-H.;Yang C.-H.;Ho H.-C.;Lin J.-Y.;Chang Y.-C.;Chen M.-J.;Lu C.-W.;Ng C.Y.;Kuo K.-L.;Lin C.-Y.;Yang C.-S.;Chen D.-P.;Chang P.-Y.;Wu T.-L.;Lin Y.-J.;Weng Y.-C.;Kuo T.-T.;Hung S.-I.;Chung W.-H.;For The Taiwan Severe Cutaneous Adverse Reaction Consortium; Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium |
| 臺大學術典藏 |
2019-12-04T08:43:28Z |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium; Huang Y.-H.; Lu C.-W.; Chiu T.-M.; Hsu C.-K.; Wu C.-Y.; Chen Y.-J.; CHIA-YU CHU; Hui R.C.-Y.; Cheng B.; Ji C.; Huang J.-W.; Cheung C.M.-T.; Wang Y.-H.;Chen C.-B.;Tassaneeyakul W.;Saito Y.;Aihara M.;Choon S.E.;Lee H.Y.;Chang M.M.;Roa F.D.;Wu C.-W.;Zhang J.;Nakkam N.;Konyoung P.;Okamoto-Uchida Y.;Cheung C.M.-T.;Huang J.-W.;Ji C.;Cheng B.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Huang Y.-H.;Lu C.-W.;Yang C.-Y.;Lin Y.-T.;Chi M.-H.;Ho H.-C.;Lin J.-Y.;Yang C.-H.;Chang Y.-C.;Su S.-C.;Wang C.W.;Fan W.-L.;Hung S.-I.;Chung W.-H.;For The Asian Severe Cutaneous Adverse Reaction Consortium; Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y. |
| 臺大學術典藏 |
2019-12-04T08:43:28Z |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium; Huang Y.-H.; Lu C.-W.; Chiu T.-M.; Hsu C.-K.; Wu C.-Y.; Chen Y.-J.; CHIA-YU CHU; Hui R.C.-Y.; Cheng B.; Ji C.; Huang J.-W.; Cheung C.M.-T.; Wang Y.-H.;Chen C.-B.;Tassaneeyakul W.;Saito Y.;Aihara M.;Choon S.E.;Lee H.Y.;Chang M.M.;Roa F.D.;Wu C.-W.;Zhang J.;Nakkam N.;Konyoung P.;Okamoto-Uchida Y.;Cheung C.M.-T.;Huang J.-W.;Ji C.;Cheng B.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Huang Y.-H.;Lu C.-W.;Yang C.-Y.;Lin Y.-T.;Chi M.-H.;Ho H.-C.;Lin J.-Y.;Yang C.-H.;Chang Y.-C.;Su S.-C.;Wang C.W.;Fan W.-L.;Hung S.-I.;Chung W.-H.;For The Asian Severe Cutaneous Adverse Reaction Consortium; Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y. |
| 國立成功大學 |
2019 |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Wang, Y.-H.;Chen, Chen C.-B.;Tassaneeyakul, W.;Saito, Y.;Aihara, M.;Choon, S.E.;Lee, H.Y.;Chang, M.M.;Roa, F.D.;Wu, C.-W.;Zhang, J.;Nakkam, Nakkam N.;Konyoung, P.;Okamoto-Uchida, Y.;Cheung, Cheung C.M.-T.;Huang, J.-W.;Ji, C.;Cheng, B.;Hui, R.C.-Y.;Chu, Chu C.-Y.;Chen, Y.-J.;Wu, C.-Y.;Hsu, C.-K.;Chiu, T.-M.;Huang, Y.-H.;Lu, C.-W.;Yang, C.-Y.;Lin, Y.-T.;Chi, M.-H.;Ho, Ho H.-C.;Lin, J.-Y.;Yang, C.-H.;Chang, Y.-C.;Su, Su S.-C.;Wang, C.W.;Fan, W.-L.;Hung, S.-I.;Chung, W.-H.;Consortium, for the Asian Severe Cutaneous Adverse Reaction |
Showing items 1-10 of 10 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
